Desitin Pharma & ChangeMed.
Transforming epilepsy treatment – development of a web database and mobile app to empower HCPs and improve patient outcomes
Desitin Pharma and ChangeMed discerned a critical gap within the healthcare sector—especially among HCPs treating epilepsy in adult and paediatric patients. They pinpointed the lack of a comprehensive, easily accessible platform that could provide essential information about anti-seizure medications, their formulations, excipients, and modes of administration. The critical need for such a resource, particularly for patients who may not be able to use traditional tablet or capsule medications, was unmet in the current healthcare landscape.
Desitin Pharma and ChangeMed partnered with Genetic Digital to develop the Epilepsy Meds web-based database and mobile application. This innovative digital solution enables healthcare professionals to access indispensable information about epilepsy medications with ease and efficiency.
Epilepsy Meds Web-Based Database
The web-based database serves as a powerful tool, allowing users to search for medications and their formulations. Clicking on a hyperlinked product name reveals more detailed information, including any identified excipients of concern, sourced directly from the manufacturer’s Summary of Product Characteristics. This ensures the information is both authentic and reliable.
Epilepsy Meds App
The Epilepsy Meds App is an anti-seizure medication finder available on Apple’s App Store and Google Play. This intuitive app enhances the user experience with additional search functionalities and filters not present on the web version.
Medical professionals can swiftly search the currently licensed anti-seizure medications by formulation, drug safety category, and excipients of concern. The app also includes options to filter search results by formulation, product name, free status of alcohol/sugar/preservative/carbohydrate, and whether the product is licensed for use with a feeding tube.
Furthermore, the app provides links to Summary of Product Characteristics (SPCs), product photos, medicine strengths, and other key characteristics to help users quickly narrow down product choices.
The Epilepsy Meds platform is emerging as a vital resource for HCPs in the field of epilepsy treatment. It enables quick and easy access to essential information about anti-seizure medications, their formulations, and excipients, thereby aiding in the improvement of patient outcomes. ChangeMed have also developed an A1 size poster for clinics and surgeries and are also developing a booklet aimed at young patients with epilepsy.
“Working with Genetic Digital on the development of our Epilepsy Meds database and mobile application was a seamless experience. The team was not only accommodating and flexible in meeting our needs, but also invaluable in providing practical advice to transform our ideas into a tangible digital product.
Their expertise was instrumental in enhancing our initial concepts, delivering a platform that exceeds expectations and serves as a critical resource for healthcare professionals. Genetic Digital’s commitment to the project and their ability to adapt quickly to changes were truly impressive.
We wholeheartedly recommend Genetic Digital to any organisation seeking a digital partner that excels in collaboration, flexibility, and innovation. Their commitment to turning ideas into impressive digital solutions is truly unmatched.”
Andy (Desitin Pharma) and Jan (ChangeMed)